Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Single-Blind, Placebo-Controlled Phase 2 Study Assessing the Safety and Efficacy of Intravenous CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure

NCT00839007 is registered in ClinicalTrials.gov with Nile Therapeutics as lead sponsor.

NCT NCT00839007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00839007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Single-Blind, Placebo-Controlled Phase 2 Study Assessing the Safety and Efficacy of Intravenous CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure
Lead sponsor
Nile Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
July 31, 2010
Enrollment
77 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure